Related references
Note: Only part of the references are listed.Ferroptosis: an iron-dependent cell death form linking metabolism, diseases, immune cell and targeted therapy
Shengxian Li et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2022)
Metabolic reprogramming from glycolysis to fatty acid uptake and beta-oxidation in platinum-resistant cancer cells
Yuying Tan et al.
NATURE COMMUNICATIONS (2022)
The Role of SLC7A11 in Cancer: Friend or Foe?
Sijia Li et al.
CANCERS (2022)
Targeting ferroptosis as a vulnerability in cancer
Guang Lei et al.
NATURE REVIEWS CANCER (2022)
Metabolic reprogramming of ovarian cancer involves ACSL1-mediated metastasis stimulation through upregulated protein myristoylation
Qingyu Zhang et al.
ONCOGENE (2021)
Characterization of SOX2, OCT4 and NANOG in Ovarian Cancer Tumor-Initiating Cells
Mikella Robinson et al.
CANCERS (2021)
Characteristics and Biomarkers of Ferroptosis
Xin Chen et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
The systemic treatment of recurrent ovarian cancer revisited
T. Baert et al.
ANNALS OF ONCOLOGY (2021)
Insights into the Role of Oxidative Stress in Ovarian Cancer
Dan-Ni Ding et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2021)
Ferroptotic cell death triggered by conjugated linolenic acids is mediated by ACSL1
Alexander Beatty et al.
NATURE COMMUNICATIONS (2021)
Ferroptosis: mechanisms and links with diseases
Hong-fa Yan et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)
ROS in cancer therapy: the bright side of the moon
Bruno Perillo et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2020)
Targeting Fatty Acid Oxidation to Promote Anoikis and Inhibit Ovarian Cancer Progression
Brandon T. Sawyer et al.
MOLECULAR CANCER RESEARCH (2020)
Lipid Regulatory Proteins as Potential Therapeutic Targets for Ovarian Cancer in Obese Women
Jing Yang et al.
CANCERS (2020)
Stearoyl-CoA Desaturase 1 Protects Ovarian Cancer Cells from Ferroptotic Cell Death
Lia Tesfay et al.
CANCER RESEARCH (2019)
FSP1 is a glutathione-independent ferroptosis suppressor
Sebastian Doll et al.
NATURE (2019)
The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis
Kirill Bersuker et al.
NATURE (2019)
Direct impact of cisplatin on mitochondria induces ROS production that dictates cell fate of ovarian cancer cells
Markus Kleih et al.
CELL DEATH & DISEASE (2019)
Exogenous Monounsaturated Fatty Acids Promote a Ferroptosis-Resistant Cell State
Leslie Magtanong et al.
CELL CHEMICAL BIOLOGY (2019)
Biomarkers of platinum resistance in ovarian cancer: what can we use to improve treatment
Belinda van Zyl et al.
ENDOCRINE-RELATED CANCER (2018)
Downregulation of SREBP inhibits tumor growth and initiation by altering cellular metabolism in colon cancer
Yang-An Wen et al.
CELL DEATH & DISEASE (2018)
Iron addiction: a novel therapeutic target in ovarian cancer
D. Basuli et al.
ONCOGENE (2017)
Autophagy promotes ferroptosis by degradation of ferritin
Wen Hou et al.
AUTOPHAGY (2016)
Anoikis resistance is a critical feature of highly aggressive ovarian cancer cells
Q. Cai et al.
ONCOGENE (2015)
Platinum resistant ovarian cancer: What is it, who to treat and how to measure benefit?
Alison Davis et al.
GYNECOLOGIC ONCOLOGY (2014)
Ovarian Cancer Spheroid Cells with Stem Cell-Like Properties Contribute to Tumor Generation, Metastasis and Chemotherapy Resistance through Hypoxia-Resistant Metabolism
Jianqun Liao et al.
PLOS ONE (2014)
Cisplatin Induces a Mitochondrial-ROS Response That Contributes to Cytotoxicity Depending on Mitochondrial Redox Status and Bioenergetic Functions
Rossella Marullo et al.
PLOS ONE (2013)
CAMERA: An Integrated Strategy for Compound Spectra Extraction and Annotation of Liquid Chromatography/Mass Spectrometry Data Sets
Carsten Kuhl et al.
ANALYTICAL CHEMISTRY (2012)
Adipose Acyl-CoA Synthetase-1 Directs Fatty Acids toward β-Oxidation and Is Required for Cold Thermogenesis
Jessica M. Ellis et al.
CELL METABOLISM (2010)
The roles of intracellular protein-degradation pathways in neurodegeneration
David C. Rubinsztein
NATURE (2006)
Share Paper
